Stryker Posts $3.52 Adjusted EPS for Third Quarter
SYK sits 17% above its 52-week low of $267.
Summary
Stryker reported third-quarter adjusted EPS of $3.52, per Dow Jones Newswires, alongside GAAP EPS of $1.96 and net income of $753M on sales of $6.5B. The company guided full-year adjusted EPS to $14.80 to $14.90. Context matters here: Q2 2026 adjusted EPS was $3.69 on net sales of $6.59B, up 9.4% year over year, and the company had narrowed full-year adjusted EPS guidance citing the March 2026 cyberattack. This print lands amid a CEO transition — Kevin Lobo steps down at year-end with the COO taking over — and after the $400M preferred equity investment in CMR Surgical.
At the time of this announcement, SYK was trading at $311.34 on NYSE in the Life Sciences sector, with a market capitalization of approximately $119.4B. The 52-week trading range was $267.00 to $389.33. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.